Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person8
Profound Medical Corp.
Company
Apyx Medical Corp
Company
ESCALON MEDICAL CORP
Company
Journey Medical Corp
Company
enVVeno Medical Corp
Company
SeaStar Medical Holding Corp
Company
Zomedica Corp.
Company
Critical Metals Corp.
Company
Primary record11
Profound Medical Corp. filed 8-K
Item 2.02. Results of Operations and Financial Condition. On November 5, 2026, Profound Medical Corp. (the “Company”) issued a press release to announce its financial results for the quarter ended September 30, 2026 and
Profound Medical Corp. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. On October 28, 2026, Profound Medical (U.S.) Inc. (“Profound U.S.”), a wholly owned subsidiary of Profound Medical Corp. (the “Company” or “Profound”), entered into
Profound Medical Corp. filed 8-K
Item 7.01. Regulation FD Disclosure. On October 22, 2026, Profound Medical Corp. (the “Company” or “Profound”) issued a press release announcing the Company’s upcoming patient education and engagement webinar. A copy of
Profound Medical Corp. filed 8-K
Item 7.01. Regulation FD Disclosure. On October 14, 2026, Profound Medical Corp. (the Company or Profound ) issued a press release announcing abstracts related to the Company s TULSA-PRO system presented at the 15th Inte
Profound Medical Corp. filed 8-K
Item 7.01. Regulation FD Disclosure. On October 9, 2026, Profound Medical Corp. (the Company or Profound ) issued a press release announcing that the Company entered into a co-education agreement with Telix Pharmaceutica
Profound Medical Corp. filed 8-K
Item 2.02. Results of Operations and Financial Condition. On October 7, 2026, Profound Medical Corp. (the Company ) issued a press release to announce certain of its preliminary unaudited financial results for the three
Profound Medical Corp. filed 8-K
Item 7.01. Regulation FD Disclosure. On September 3, 2026, Profound Medical Corp. (the Company or Profound ) issued a press release announcing that the Company s management will participate in the Lake Street Capital Mar
Profound Medical Corp. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of President On September 1, 2026, Profound Medica
Profound Medical Corp. filed 8-K
Item 7.01. Regulation FD Disclosure. On August 17, 2026, Profound Medical Corp. (the “Company” or “Profound”) issued a press release announcing the introduction of the Company’s new real-time interventional MRI Software.
Profound Medical Corp. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Interim Chief Financial Officer On August 14, 2
Profound Medical Corp. filed 8-K
Item 7.01. Regulation FD Disclosure. On August 13, 2026, Profound Medical Corp. (the “Company” or “Profound”) issued a press release announcing the launch of Let’s Huddle , a patient advocacy initiative. A copy of the pr